MARINOMED BIOTECH AG |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.8 EUR | +2.81% |
|
-4.96% | -58.64% |
| 05-22 | Transcript : Marinomed Biotech AG, Q1 2024 Earnings Call, May 22, 2024 | |
| 05-21 | Marinomed Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 94.76B | ||||||
| 37.58B | ||||||
| 33.3B | ||||||
| 27.92B | ||||||
| 15.85B |
